Biotronik/Aachen Lekton Vita DES Slated For Q4 2004 European Launch
This article was originally published in The Gray Sheet
Executive Summary
Aachen Resonance will begin a randomized trial of its Tretinoin compound on Biotronik's Lekton Motion stent system early next year under a Nov. 19 pact giving Biotronik commercialization rights